Role of Pannexin-1 hemichannels and purinergic receptors in the pathogenesis of human diseases

Frontiers in Physiology

Volumn 5 MAR, Issue , 2014, Pages

  Velasquez, Stephani ^a,b   Eugenin, Eliseo A ^a,b  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Atherosclerosis; ATP; Connexins; HIV; Inflammation

Indexed keywords

ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; INFLAMMASOME; MEMBRANE PROTEIN; PANNEXIN 1; PURINERGIC RECEPTOR; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR CXCR4; CLOPIDOGREL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PRASUGREL; PURINERGIC P2X RECEPTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; REGADENOSON; TICAGRELOR; TICLOPIDINE;

APOPTOSIS; ATHEROSCLEROSIS; BRAIN ISCHEMIA; DRUG TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFLAMMATION; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; ATHEROSCLEROTIC PLAQUE; BINDING AFFINITY; CELL MIGRATION; DRUG APPROVAL; DRUG EFFICACY; DRUG RESPONSE; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; LIPOGENESIS; MYOCARDIAL PERFUSION IMAGING; PATHOGENESIS; PHARMACOLOGICAL BLOCKING; PNEUMONIA; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN SECRETION; RECEPTOR BLOCKING; THROMBOCYTE AGGREGATION; UNSPECIFIED SIDE EFFECT; VIRUS ENTRY; VIRUS REPLICATION;

EID: 84895464144     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00096     Document Type: Review

References (156)

1. Abbracchio, M. P., and Burnstock, G. (1998). Purinergic signaling: pathophysiological roles. Jpn. J. Pharmacol. 78, 113-145. doi: 10.1254/jjp.78.113.
2. Adair, T. H. (2005). Growth regulation of the vascular system: an emerging role for adenosine. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R283-R296. doi: 10.1152/ajpregu.00840.2004.
3. Antonioli, L., Pacher, P., Vizi, E. S., and Haskó, G. (2013). CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 19, 355-367. doi: 10.1016/j.molmed.2013.03.005.
4. Arthos, J., Rubbert, A., Rabin, R. L., Cicala, C., Machado, E., Wildt, K., et al. (2000). CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes. J. Virol. 74, 6418-6424. doi: 10.1128/JVI.74.14.6418-6424.2000.
5. Ayna, G., Krysko, D. V., Kaczmarek, A., Petrovski, G., and Vandenabeele, P. (2012). ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages. PLoS ONE 7:e40069. doi: 10.1371/journal.pone.0040069.
6. Balabanian, K., Harriague, J., Décrion, C., Lagane, B., Shorte, S., Baleux, F., et al. (2004). CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes. J. Immunol. 173, 7150-7160.
7. Bao, B. A., Lai, C. P., Naus, C. C., and Morgan, J. R. (2012). Pannexin1 drives multicellular aggregate compaction via a signaling cascade that remodels the actin cytoskeleton. J. Biol. Chem. 287, 8407-8416. doi: 10.1074/jbc.M111.306522.
8. Bao, Y., Chen, Y., Ledderose, C., Li, L., and Junger, W. G. (2013). Pannexin 1 channels link chemoattractant receptor signaling to local excitation and global inhibition responses at the front and back of polarized neutrophils. J. Biol. Chem. 288, 22650-22657. doi: 10.1074/jbc.M113.476283.
9. Baranova, A., Ivanov, D., Petrash, N., Pestova, A., Skoblov, M., Kelmanson, I., et al. (2004). The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins. Genomics 83, 706-716. doi: 10.1016/j.ygeno.2003.09.025.
10. Barbe, M. T., Monyer, H., and Bruzzone, R. (2006). Cell-cell communication beyond connexins: the pannexin channels. Physiology (Bethesda) 21, 103-114. doi: 10.1152/physiol.00048.2005.
11. Bargiotas, P., Krenz, A., Hormuzdi, S. G., Ridder, D. A., Herb, A., Barakat, W., et al. (2011). Pannexins in ischemia-induced neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 108, 20772-20777. doi: 10.1073/pnas.1018262108.
12. 2+ homeostasis and apoptosis. EMBO J. 23, 1207-1216. doi: 10.1038/sj.emboj.7600104.
13. Berzat, A., and Hall, A. (2010). Cellular responses to extracellular guidance cues. EMBO J. 29, 2734-2745. doi: 10.1038/emboj.2010.170.
14. Boassa, D., Ambrosi, C., Qiu, F., Dahl, G., Gaietta, G., and Sosinsky, G. (2007). Pannexin1 channels contain a glycosylation site that targets the hexamer to the plasma membrane. J. Biol. Chem. 282, 31733-31743. doi: 10.1074/jbc.M702422200.
15. Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., et al. (2007). Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225-1232. doi: 10.1182/blood-2006-12-064527.
16. Bours, M. J., Swennen, E. L., Di Virgilio, F., Cronstein, B. N., and Dagnelie, P. C. (2006). Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112, 358-404. doi: 10.1016/j.pharmthera.2005.04.013.
17. Bruzzone, R., Barbe, M. T., Jakob, N. J., and Monyer, H. (2005). Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J. Neurochem. 92, 1033-1043. doi: 10.1111/j.1471-4159.2004.02947.x.
18. Bruzzone, R., and Dermietzel, R. (2006). Structure and function of gap junctions in the developing brain. Cell Tissue Res. 326, 239-248. doi: 10.1007/s00441-006-0287-0.
19. Bruzzone, R., Hormuzdi, S. G., Barbe, M. T., Herb, A., and Monyer, H. (2003). Pannexins, a family of gap junction proteins expressed in brain. Proc. Natl. Acad. Sci. U.S.A. 100, 13644-13649. doi: 10.1073/pnas.2233464100.
20. Buchheiser, A., Ebner, A., Burghoff, S., Ding, Z., Romio, M., Viethen, C., et al. (2011). Inactivation of CD73 promotes atherogenesis in apolipoprotein E-deficient mice. Cardiovasc. Res. 92, 338-347. doi: 10.1093/cvr/cvr218.
21. Burnstock, G. (2006). Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev. 58, 58-86. doi: 10.1124/pr.58.1.5.
22. Burnstock, G. (2012). Purinergic signalling: its unpopular beginning, its acceptance and its exciting future. Bioessays 34, 218-225. doi: 10.1002/bies.201100130.
23. Burnstock, G., and Knight, G. E. (2004). Cellular distribution and functions of p2 receptor subtypes in different systems. Int. Rev. Cytol. 240, 31-304. doi: 10.1016/S0074-7696(04)40002-3.
24. Burnstock, G., and Verkhratsky, A. (2010). Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death. Cell Death Dis. 1, e9. doi: 10.1038/cddis.2009.11.
25. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., et al. (1998). Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485-490. doi: 10.1038/28867.
26. Cattaneo, M. (2010). New P2Y12 inhibitors. Circulation 121, 171-179. doi: 10.1161/CIRCULATIONAHA.109.853069.
27. Cavaliere, F., Amadio, S., Dinkel, K., Reymann, K. G., and Volonte, C. (2007). P2 receptor antagonist trinitrophenyl-adenosine-triphosphate protects hippocampus from oxygen and glucose deprivation cell death. J. Pharmacol. Exp. Ther. 323, 70-77. doi: 10.1124/jpet.106.119024.
28. Cavaliere, F., Florenzano, F., Amadio, S., Fusco, F. R., Viscomi, M. T., D'Ambrosi, N., et al. (2003). Up-regulation of p2x2, p2x4 receptor and ischemic cell death: prevention by p2 antagonists. Neuroscience 120, 85-98. doi: 10.1016/S0306-4522(03)00228-8.
29. Cavaliere, F., Sancesario, G., Bernardi, G., and Volonté, C. (2002). Extracellular ATP and nerve growth factor intensify hypoglycemia-induced cell death in primary neurons: role of P2 and NGFRp75 receptors. J. Neurochem. 83, 1129-1138. doi: 10.1046/j.1471-4159.2002.01205.x.
30. Chekeni, F. B., Elliott, M. R., Sandilos, J. K., Walk, S. F., Kinchen, J. M., Lazarowski, E. R., et al. (2010). Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature 467, 863-867. doi: 10.1038/nature09413.
31. Chen, Y., Corriden, R., Inoue, Y., Yip, L., Hashiguchi, N., Zinkernagel, A., et al. (2006). ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314, 1792-1795. doi: 10.1126/science.1132559.
32. Chen, Y., Yao, Y., Sumi, Y., Li, A., To, U. K., Elkhal, A., et al. (2010). Purinergic signaling: a fundamental mechanism in neutrophil activation. Sci. Signal. 3, ra45. doi: 10.1126/scisignal.2000549.
33. Cotrina, M. L., Lin, J. H. C., and Nedergaard, M. (1998). Cytoskeletal assembly and ATP release regulate astrocytic calcium signaling. J. Neurosci. 18, 8794-8804.
34. Cruz, C. M., Rinna, A., Forman, H. J., Ventura, A. L., Persechini, P. M., and Ojcius, D. M. (2007). ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 282, 2871-2879. doi: 10.1074/jbc.M608083200.
35. Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., et al. (2005). ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8, 752-758. doi: 10.1038/nn1472.
36. Davis, B. K., Wen, H., and Ting, J. P. (2011). The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29, 707-735. doi: 10.1146/annurev-immunol-031210-101405.
37. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., et al. (2007). Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression J. Exp. Med. 204, 1257-1265. doi: 10.1084/jem.20062512.
38. Delacrétaz, E. (2006). Clinical practice. Supraventricular tachycardia. N. Engl. J. Med. 354, 1039-1051. doi: 10.1056/NEJMcp051145.
39. Diezmos, E. F., Sandow, S. L., Markus, I., Shevy Perera, D., Lubowski, D. Z., King, D. W., et al. (2013). Expression and localization of pannexin-1 hemichannels in human colon in health and disease. J. Neurogastroenterol. Motil. 25, e395-e405. doi: 10.1111/nmo.12130.
40. Dirnagl, U., Iadecola, C., and Moskowitz, M. A. (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397. doi: 10.1016/S0166-2236(99)01401-0.
41. Di Virgilio, F. (2007). Liaisons dangereuses: P2X(7). and the inflammasome. Trends Pharmacol. Sci. 28, 465-472. doi: 10.1016/j.tips.2007.07.002.
42. Di Virgilio, F., Ceruti, S., Bramanti, P., and Abbracchio, M. P. (2009). Purinergic signalling in inflammation of the central nervous system. Trends Neurosci. 32, 79-87. doi: 10.1016/j.tins.2008.11.003.
43. Domercq, M., Perez-Samartin, A., Aparicio, D., Alberdi, E., Pampliega, O., and Matute, C. (2010). P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia 58, 730-740. doi: 10.1002/glia.20958.
44. Dwyer, K. M., Hanidziar, D., Putheti, P., Hill, P. A., Pommey, S., McRae, J. L., et al. (2010). Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am. J. Transplant. 10, 2410-2420. doi: 10.1111/j.1600-6143.2010.03291.x.
45. Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., et al. (2009). Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461, 282-286. doi: 10.1038/nature08296.
46. Eltzschig, H. K., and Carmeliet, P. (2011). Hypoxia and Inflammation. N. Engl. J. Med. 364, 656-665. doi: 10.1056/NEJMra0910283.
47. Eltzschig, H. K., and Eckle, T. (2011). Ischemia and reperfusion-from mechanism to translation. Nat. Med. 17, 1391-1401. doi: 10.1038/nm.2507.
48. Erlinge, D., and Burnstock, G. (2008). P2 receptors in cardiovascular regulation and disease. Purinergic Signal. 4, 1-20. doi: 10.1007/s11302-007-9078-7.
49. Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., et al. (2006). The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176, 3877-3883.
50. Ferrara, N., Gerber, H. P., and LeCouter, J. (2003). The biology of VEGF and its receptors. Nat. Med. 9, 669-676. doi: 10.1038/nm0603-669.
51. Ferraris, V. A., Saha, S. P., Oestreich, J. H., Song, H. K., Rosengart, T., Reece, T. B., et al. (2012). Society of Thoracic Surgeons 2012 update to the society of thoracic surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann. Thorac. Surg. 94, 1761-1781. doi: 10.1016/j.athoracsur.2012.07.086.
52. Fredholm, B. B. (2007). Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 14, 1315-1323. doi: 10.1038/sj.cdd.4402132.
53. Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, K., Jacobson, K. A., et al. (1994). Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46, 143-156.
54. Gessi, S., Fogli, E., Sacchetto, V., Merighi, S., Varani, K., Preti, D., et al. (2010). Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells. Arterioscler. Thromb. Vasc. Biol. 30, 90-97. doi: 10.1161/ATVBAHA.109.194902.
55. Ghimire, G., Hage, F. G., Heo, J., and Iskandrian, A. E. (2013). Regadenoson: a focused update. J. Nucl. Cardiol. 20, 284-288. doi: 10.1007/s12350-012-9661-3.
56. Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., et al. (2009). Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 15, 1170-1178. doi: 10.1038/nm.2028.
57. Glass, C. K., and Witztum, J. L. (2001). Atherosclerosis: The Road Ahead. Cell 104, 503-516. doi: 10.1016/S0092-8674(01)00238-0.
58. Gorski, D. H., and Walsh, K. (1995). Mitogen-responsive nuclear factors that mediate growth control signals in vascular myocytes. Cardiovasc. Res. 30, 585-592. doi: 10.1016/S0008-6363(96)88508-7.
59. Grenz, A., Bauerle, J. D., Dalton, J. H., Ridyard, D., Badulak, A., Tak, E., et al. (2012). Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J. Clin. Invest. 122, 693-710. doi: 10.1172/JCI60214.
60. Gulbransen, B. D., Bashashati, M., Hirota, S. A., Gui, X., Roberts, J. A., MacDonald, J. A., et al. (2012). Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat. Med. 18, 600-604. doi: 10.1038/nm.2679.
61. Hansson, G. K., and Hermansson, A. (2011). The immune system in atherosclerosis. Nat. Immunol. 12, 204-212. doi: 10.1038/ni.2001.
62. Harris, A. L. (2007). Connexin channel permeability to cytoplasmic molecules. Prog. Biophys. Mol. Biol. 94, 120-143. doi: 10.1016/j.pbiomolbio.2007.03.011.
63. Haskó, G., Linden, J., Cronstein, B., and Pacher, P. (2008). Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7, 759-770. doi: 10.1038/nrd2638.
64. Hazleton, J. E., Berman, J. W., and Eugenin, E. A. (2012). Purinergic receptors are required for HIV-1 infection of primary human macrophages. J. Immunol. 188, 4488-4495. doi: 10.4049/jimmunol.1102482.
65. Hou, M., Moller, S., Edvinsson, L., and Erlinge, D. (2000). Cytokines induce upregulation of vascular P2Y2 receptors and increased mitogenic responses to UTP and ATP. Arterioscler. Thromb. Vasc. Biol. 20, 2064-2069. doi: 10.1161/01.ATV.20.9.2064.
66. Huang, C., Han, X., Li, X., Lam, E., Peng, W., Lou, N., et al. (2012). Critical role of connexin 43 in secondary expansion of traumatic spinal cord injury. J. Neurosci. 32, 3333-3338. doi: 10.1523/JNEUROSCI.1216-11.2012.
67. Huang, Z. L., Qu, W. M., Eguchi, N., Chen, J. F., Schwarzschild, M. A., Fredholm, B. B., et al. (2005). Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat. Neurosci. 8, 858-859. doi: 10.1038/nn1491.
68. Hung, S. C., Choi, C. H., Said-Sadier, N., Johnson, L., Atanasova, K. R., Sellami, H., et al. (2013). P2X4 assembles with P2X7 and pannexin-1 in gingival epithelial cells and modulates ATP-induced reactive oxygen species production and inflammasome activation. PLoS ONE 8:e70210. doi: 10.1371/journal.pone.0070210.
69. Idzko, M., Hammad, H., van Nimwegen, M., Kool, M., Willart, M. A., Muskens, F., et al. (2007). Extracellu8lar ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13, 913-919. doi: 10.1038/nm1617.
70. Iglesias, R., Dahl, G., Qiu, F., Spray, D. C., and Scemes, E. (2009). Pannexin 1: the molecular substrate of astrocyte "hemichannels". J. Neurosci. 29, 7092-7097. doi: 10.1523/JNEUROSCI.6062-08.2009.
71. Jacobson, K. A., and Gao, Z. G. (2006). Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5, 247-264. doi: 10.1038/nrd1983.
72. James, G., and Butt, A. M. (2001). P2X and P2Y purinoreceptors mediate ATP-evoked calcium signalling in optic nerve glia in situ. Cell Calcium 30, 251-259. doi: 10.1054/ceca.2001.0232.
73. Ji, X., and Hou, M. (2011). Novel agents for antiplatelet therapy. J. Hematol. Oncol. 4, 4-44. doi: 10.1186/1756-8722-4-44.
74. Jiang, G., Li, T., Qiu, Y., Rui, Y., Chen, W., and Lou, Y. (2007). RNA interference for HIF-1alpha inhibits foam cells formation in vitro. Eur. J. Pharmacol. 562, 183-190. doi: 10.1016/j.ejphar.2007.01.066.
75. Jiang, L. H., Mackenzie, A. B., North, R. A., and Surprenant, A. (2000). Brilliant Blue G selectively blocks ATP-gated rat P2X7 receptors. Mol. Pharmacol. 58, 82-88. doi: 10.1124/mol.58.1.82.
76. Johansson, S. M., Yang, J. N., Lindgren, E., and Fredholm, B. B. (2007). Eliminating the antilipolytic adenosine A1 receptor does not lead to compensatory changes in the antilipolytic actions of PGE2 and nicotinic acid. Acta Physiol. 190, 87-96. doi: 10.1111/j.1365-201X.2007.01692.x.
77. Jonzon, B., Nilsson, J., and Fredholm, B. B. (1985). Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells. J. Cell. Physiol. 124, 451-456. doi: 10.1002/jcp.1041240314.
78. Junger, W. G. (2011). Immune cell regulation by autocrine purinergic signalling. Nat. Rev. Immunol. 11, 201-212. doi: 10.1038/nri2938.
79. Kanneganti, T. D., Body-Malapel, M., Amer, A., Park, J. H., Whitfield, J., Franchi, L., et al. (2006). Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281, 36560-36568. doi: 10.1074/jbc.M607594200.
80. Katsura, K., Kristian, T., and Siesjo, B. K. (1994). Energy metabolism, ion homeostasis, and cell damage in the brain. Biochem. Soc. Trans. 22, 991-996.
81. Kirischuk, S., Scherer, J., Kettenmann, H., and Verkhratsky, A. (1995). Activa-tion of P2-purinoreceptors triggered Ca21 release from InsP3-sensi-tive internal stores in mammalian oligodendrocytes. J. Physiol. 483, 41-57.
82. Koupenova, M., Johnston-Cox, H., and Ravid, K. (2012b). Regulation of atherosclerosis and associated risk factors by adenosine and adenosine receptors. Curr. Atheroscler. Rep. 14, 460-468. doi: 10.1007/s11883-012-0263-y.
83. Koupenova, M., Johnston-Cox, H., Vezeridis, A., Gavras, H., Yang, D., Zannis, V., et al. (2012a). A2b adenosine receptor regulates hyperlipidemia and atherosclerosis. Circulation 125, 354-363. doi: 10.1161/CIRCULATIONAHA.111.057596.
84. Kourembanas, S., Morita, T., Christou, H., Liu, Y., Koike, H., Brodsky, D., et al. (1998). Hypoxic responses of vascular cells. Chest 114, 25S-28S. doi: 10.1378/chest.114.1_Supplement.25S-a.
85. Lacombe, C., and Mayeux, P. (1998). Biology of erythropoietin. Haematologica 83, 724-732.
86. Lammer, A., Gunther, A., Beck, A., Krugel, U., Kittner, H., Schneider, D., et al. (2006). Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats. Eur. J. Neurosci. 23, 2824-2828. doi: 10.1111/j.1460-9568.2006.04825.x.
87. Lammer, A. B., Beck, A., Grummich, B., Forschler, A., Krugel, T., Kahn, T., et al. (2011). The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo. PLoS ONE 6:e19983. doi: 10.1371/journal.pone.0019983.
88. Lazarus, M., Shen, H. Y., Cherasse, Y., Qu, W. M., Huang, Z. L., Bass, C. E., et al. (2011). Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J. Neurosci. 31, 10067-10075. doi: 10.1523/JNEUROSCI.6730-10.2011.
89. Lich, J. D., Arthur, J. C., and Ting, J. P. (2006). Cryopyrin: in from the cold. Immunity 24, 241-243. doi: 10.1016/j.immuni.2006.03.004.
90. Liu, Q. H., Williams, D. A., McManus, C., Baribaud, F., Doms, R. W., Schols, D., et al. (2000). HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. Proc. Natl. Acad. Sci. U.S.A. 97, 4832-4837. doi: 10.1073/pnas.090521697.
91. Liu, X. L., Zhou, R., Pan, Q. Q., Jia, X. L., Gao, W. N., Wu, J., et al. (2010). Genetic inactivation of the adenosine A2A receptor attenuates pathologic but not developmental angiogenesis in the mouse retina. Invest. Ophthalmol. Vis. Sci. 51, 6625-6632. doi: 10.1167/iovs.09-4900.
92. Liu, Y., Cox, S. R., Morita, T., and Kourembanas, S. (1995). Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5'enhancer. Circ. Res. 77, 638-643. doi: 10.1161/01.RES.77.3.638.
93. Locovei, S., Scemes, E., Qiu, F., Spray, D. C., and Dahl, G. (2007). Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex. FEBS Lett. 581, 483-488. doi: 10.1016/j.febslet.2006.12.056.
94. Lommatzsch, M., Cicko, S., Muller, T., Lucattelli, M., Bratke, K., Stoll, P., et al. (2010). Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 181, 928-934. doi: 10.1164/rccm.200910-1506OC.
95. MacVicar, B. A., and Thompson, R. J. (2010). Non-junction functions of pannexin-1 channels. Trends Neurosci. 33, 93-102. doi: 10.1016/j.tins.2009.11.007.
96. Madry, C., Haglerod, C., and Attwell, D. (2010). The role of pannexin hemichannels in the anoxic depolarization of hippocampal pyramidal cells. Brain 133, 3755-3763., doi: 10.1093/brain/awq284.
97. Mandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., et al. (2010). Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J. Biol. Chem. 285, 7176-7186. doi: 10.1074/jbc.M109.047423.
98. Mandapathil, M., Lang, S., Gorelik, E., and Whiteside, T. L. (2009). Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J. Immunol. Methods. 346, 55-63. doi: 10.1016/j.jim.2009.05.004.
99. Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., et al. (2006). Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232. doi: 10.1038/nature04515.
100. Martin, R. L., Lloyd, H. G., and Cowan, A. I. (1994). The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci. 17, 251-257. doi: 10.1016/0166-2236(94)90008-6.
101. Mawe, G. M., Strong, D. S., and Sharkey, K. A. (2009). Plasticity of enteric nerve functions in the inflamed and postinflamed gut. Neurogastroenterol. Motil. 21, 481-491. doi: 10.1111/j.1365-2982.2009.01291.x.
102. Melar, M., Ott, D. E., and Hope, T. J. (2007). Physiological levels of virion-associated human immunodeficiency virus type 1 envelope induce coreceptor-dependent calcium flux. J. Virol. 81, 1773-1785. doi: 10.1128/JVI.01316-06.
103. Meylan, E., Tschopp, J., and Karin, M. (2006). Intracellular pattern recognition receptors in the host response. Nature 442, 39-44. doi: 10.1038/nature04946.
104. Mohelmani, F., and Jackson, D. E. (2012). P2Y(12) receptor: Platelet thrombus formation and medical interventions. Int. J. Hematol. 96, 572-587. doi: 10.1007/s12185-012-1188-5.
105. Moore, K. J., and Tabas, I. (2011). Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341-355. doi: 10.1016/j.cell.2011.04.005.
106. Nimmerjahn, A., Kirchhoff, F., and Helmchen, F. (2005). Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318. doi: 10.1126/science.1110647.
107. Oakes, S. A., Scorrano, L., Opferman, J. T., Bassik, M. C., Nishino, M., Pozzan, T., et al. (2005). Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 102, 105-110. doi: 10.1073/pnas.0408352102.
108. Ohta, A., Kini, R., Ohta, A., Subramanian, M., Madasu, M., and Sitkovsky, M. (2012). The development and immunosuppressive functions of CD4+ CD25+ FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway. Front. Immunol. 3:190. doi: 10.3389/fimmu.2012.00190.
109. Orellana, J. A., Froger, N., Ezan, P., Jiang, J. X., Bennett, M. V., Naus, C. C., et al. (2011). ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J. Neurochem. 118, 826-840. doi: 10.1111/j.1471-4159.2011.07210.x.
110. Orellana, J. A., Velasquez, S., Williams, D. W., Saez, J. C., Berman, J. W., and Eugenin, E. A. (2013). Pannexin1 hemichannels are critical for HIV infection of human primary CD4+ T lymphocytes. J. Leukoc. Biol. 94, 399-407. doi: 10.1189/jlb.0512249.
111. Pelegrin, P. (2008). Targeting interleukin-1 signaling in chronic inflammation: focus on P2X(7) receptor and Pannexin-1. Drug News Perspect. 21, 424-433.
112. Pelegrin, P., and Surprenant, A. (2006). Pannexin-1 mediates large pore formation and interleukin-1b release by the ATP-gated P2X7 receptor. EMBO J. 25, 5071-5082. doi: 10.1038/sj.emboj.7601378.
113. Peng, W., Cotrina, M. L., Han, X., Yu, H., Bekar, L., Blum, L., et al. (2009). Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 106, 12489-12493. doi: 10.1073/pnas.0902531106.
114. Penuela, S., Bhalla, R., Gong, X. Q., Cowan, K. N., Celetti, S. J., Cowan, B. J., et al. (2007). Pannexin 1 and pannexin 3 are glycoproteins that exhibit many distinct characteristics from the connexin family of gap junction proteins. J. Cell Sci. 120, 3772-3783. doi: 10.1242/jcs.009514.
115. Peters, M. A., Teramoto, T., White, J. Q., Iwasaki, K., and Jorgensen, E. M. (2007). A calcium wave mediated by gap junctions coordinates a rhythmic behavior in C. elegans. Curr. Biol. 17, 1601-1608. doi: 10.1016/j.cub.2007.08.031.
116. 2+ mobilization and cell proliferation. J. Biol. Chem. 288, 27571-27583. doi: 10.1074/jbc.M113.460865.
117. Pinton, P. D., Ferrari, P., Magalhaes, K., Schulze-Osthoff, F., Di Virgilio, T., and Pozzan, R., Rizzuto. (2000). Reduced loading of intracellular Ca(2+) stores and downregulation of capacitative Ca(2+) influx in Bcl-2-overexpressing cells. J. Cell Biol. 148, 857-862. doi: 10.1083/jcb.148.5.857.
118. Power, R. F., Hynes, B. G., Moran, D., Yagoub, H., Kiernan, G., Ruggiero, N. J., et al. (2012). Modern antiplatelet agents in coronary artery disease. Expert Rev. Cardiovasc. Ther. 10, 1261-1272. doi: 10.1586/erc.12.127.
119. Prochnow, N., Abdulazim, A., Kurtenbach, S., Wildförster, V., Dvoriantchikova, G., Hanske, J., et al. (2012). Pannexin1 stabilizes synaptic plasticity and is needed for learning. PLoS ONE 7:e51767. doi: 10.1371/journal.pone.0051767.
120. Qiu, F., and Dahl, G. (2009). A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP. Am. J. Physiol. Cell Physiol. 296, C250-C255. doi: 10.1152/ajpcell.00433.2008.
121. Qu, Y., Misaghi, S., Newton, K., Gilmour, L. L., Louie, S., Cupp, J. E., et al. (2011). Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J. Immunol. 186, 6553-6561. doi: 10.4049/jimmunol.1100478.
122. Ralevic, V., and Burnstock, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-492.
123. Ray, A., Zoidl, G., Wahle, P., and Dermietzel, R. (2006). Pannexin expression in the cerebellum. Cerebellum 5, 189-192. doi: 10.1080/14734220500530082.
124. Reiss, A. B., and Glass, A. D. (2006). Atherosclerosis: immune and inflammatory aspects. J. of Invest. Med. 54, 123-131. doi: 10.2310/6650.2006.05051.
125. Riteau, N., Gasse, P., Fauconnier, L., Gombault, A., Couegnat, M., Fick, L., et al. (2010). Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 182, 774-783. doi: 10.1164/rccm.201003-0359OC.
126. Romio, M., Reinbeck, B., Bongardt, S., Hüls, S., Burghoff, S., and Schrader, J. (2011). Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells. Am. J. Physiol. Cell Physiol. 301, C530-C539. doi: 10.1152/ajpcell.00385.2010.
127. Rose, F., Grimminger, F., Appel, J., Heller, M., Pies, V., Weissmann, N., et al. (2002). Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells: role of hypoxia-inducible transcription factors. FASEB J. 16, 1660-1661. doi: 10.1096/fj.02-0420fje.
128. Rosenberger, P., Schwab, J. M., Mirakaj, V., Masekowsky, E., Mager, A., Morote-Garcia, J. C., et al. (2009). Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol. 10, 195-202. doi: 10.1038/ni.1683.
129. Said-Sadier, N., and Ojcius, D. M. (2012). Alarmins, inflammasomes and immunity. Biomed. J. 35, 437-449. doi: 10.4103/2319-4170.104408.
130. Sandilos, J. K., Chiu, Y. H., Chekeni, F. B., Armstrong, A. J., Walk, S. F., Ravichandran, K. S., et al. (2012). Pannexin 1, an ATP release channel, is activated by caspase cleavage of its pore-associated C terminal autoinhibitory region. J. Biol. Chem. 287, 11303-11311. doi: 10.1074/jbc.M111.323378.
131. Scemes, E., Spray, D. C., and Meda, P. (2009). Connexins, pannexins, innexins: novel roles of "hemi-channels". Pflugers Arch. 457, 1207-1226. doi: 10.1007/s00424-008-0591-5.
132. Schenk, U., Westendorf, A. M., Radaelli, E., Casati, A., Ferro, M., Fumagalli, M., et al. (2008). Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci. Signal. 1, ra6. doi: 10.1126/scisignal.1160583.
133. Schroder, K., and Tschopp, J. (2010). The inflammasomes. Cell 140, 821-832. doi: 10.1016/j.cell.2010.01.040.
134. Schuler, P. J., Harasymczuk, M., Schilling, B., Lang, S., and Whiteside, T. L. (2011). Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets. J. Immunol. Methods 369, 59-68. doi: 10.1016/j.jim.2011.04.004.
135. 2+: a control point for apoptosis. Science 300, 135-139. doi: 10.1126/science.1081208.
136. Semenza, G. L., Roth, P. H., Fang, H. M., and Wang, G. L. (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757-23763.
137. Seror, C., Melki, M. T., Subra, F., Raza, S. Q., Bras, M., Saidi, H., et al. (2011). Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection. J. Exp. Med. 208, 1823-1834. doi: 10.1084/jem.20101805.
138. Shatrov, V. A., Sumbayev, V. V., Zhou, J., and Brune, B. (2003). Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1alpha (HIF-1alpha) accumulation via redox-dependent mechanisms. Blood 101, 4847-4849. doi: 10.1182/blood-2002-09-2711.
139. Stary, H. C., Chandler, A. B., Glagov, S., Guyton, J. R., Insull, W., Rosenfeld, M. E., et al. (1994). A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89, 2462-2478. doi: 10.1161/01.CIR.89.5.2462.
140. 2+ signaling. J. Neurosci. 26, 1378-1385. doi: 10.1523/JNEUROSCI.3902-05.2006.
141. Sun, D., Samuelson, L. C., Yang, T., Huang, Y., Paliege, A., Saunders, T., et al. (2001). Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 9983-9988. doi: 10.1073/pnas.171317998.
142. Sutterwala, F. S., Ogura, Y., Szczepanik, M., Lara-Tejero, M., Lichtenberger, G. S., Grant, E. P., et al. (2006). Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24, 317-327. doi: 10.1016/j.immuni.2006.02.004.
143. Tam, G. M., Lam, Y. Y., and Yan, B. P. (2012). Novel platelet ADP P2Y12 inhibitors in the treatment of acute coronary syndrome. Cardiovasc. Ther. 30, 167-173. doi: 10.1111/j.1755-5922.2011.00262.x.
144. Thompson, R. J., Jackson, M. F., Olah, M. E., Rungta, R. L., Hines, D. J., Beazely, M. A., et al. (2008). Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus. Science 322, 1555-1559. doi: 10.1126/science.1165209.
145. Thompson, R. J., Zhou, N., and MacVicar, B. A. (2006). Ischemia opens neuronal gap junction hemichannels. Science 312, 924-927. doi: 10.1126/science.1126241.
146. Vanden Abeele, F., Bidaux, G., Gordienko, D., Beck, B., Panchin, Y. V., Baranova, A. V., et al. (2006). Functional implications of calcium permeability of the channel formed by pannexin 1. J. Cell Biol. 174, 535-546. doi: 10.1083/jcb.200601115.
147. Vanden Abeele, F. R., Skryma, Y., Shuba, F., Van Coppenolle, C., Slomianny, M., Roudbaraki, B., et al. (2002). Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 1, 169-179. doi: 10.1016/S1535-6108(02)00034-X.
148. van Giezen, J. J., and Humphries, R. G. (2005). Preclinical and clinical studies with selective reversible direct P2Y12 inhibitors. Semin. Thromb. Hemost. 31, 195-204. doi: 10.1055/s-2005-869525.
149. Wang, G. L., and Semenza, G. L. (1995). Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230-1237. doi: 10.1074/jbc.270.3.1230.
150. Wang, J., Jackson, D. G., and Dahl, G. (2013). The food dye FD&C Blue No., 1 is a selective inhibitor of the ATP release channel Panx1. J. Gen. Physiol. 141, 649-656. doi: 10.1085/jgp.201310966.
151. Watson, M. L., Grix, S. P., Jordan, N. J., Place, G. A., Dodd, S., Leithead, J., et al. (1998). Interleukin 8 and monocyte chemoattractant protein 1 production by cultured human airway smooth muscle cells. Cytokine 10, 346-352. doi: 10.1006/cyto.1997.0350.
152. Weilinger, N. L., Tang, P. L., and Thompson, R. J. (2012). Anoxia-induced NMDA receptor activation opens pannexin channels via Src family kinases. J. Neurosci. 32, 12579-12588. doi: 10.1523/JNEUROSCI.1267-12.2012.
153. Weissman, D., Rabin, R. L., Arthos, J., Rubbert, A., Dybul, M.,
154. Woehrle, T., Yip, L., Elkhal, A., Sumi, Y., Chen, Y., Yao, Y., et al. (2010). Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse. Blood 116, 3475-3484. doi: 10.1182/blood-2010-04-277707.
155. Xiong, X. X., Gu, L. J., Shen, J., Kang, X. H., Zheng, Y. Y., Yue, S. B., et al. (2014). Probenecid protects against transient focal cerebral ischemic injury by inhibiting HMGB1 release and attenuating AQP4 expression in mice. Neurochem. Res. 39, 216-224. doi: 10.1007/s11064-013-1212-z.
156. Yegutkin, G. G. (2008). Nucleotide-and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 1783, 673-694. doi: 10.1016/j.bbamcr.2008.01.024.